Capstone Holding Corp (CAPS) Quote

CAPS....................https://stockcharts.com/h-sc/ui?s=CAPS&p=W&b=5&g=0&id=p86431144783

CAPS..........................https://stockcharts.com/h-sc/ui?s=CAPS&p=W&b=5&g=0&id=p86431144783

Peptides rising again $3.30+ 66% 

$CAPS: Out at $3.40......................

Will give her another go........... maybe a rinser repeater here for the day.


WOoooooooooooooooooooooooooooo


GO $CAPS

$CAPS: YEsssssssssssssssssssssssssssssssssssssssss

What timing :)


GO $CAPS

$CAPS: Added 6k here at $3

With a tight stop.............. just let her go for today please


GO $CAPS

$CAPS: Lá Fhéile Pádraig faoi mhaise duit !

Boosted then busted........... from $2.40 to $6.40 and back to $2.70 now.

Be Vigilant & Be Careful.......... but most Importanly be Lucky & PROSPEROUS !!!!!!!!




GO $CAPS

Get in INVU instead. Just bought back 1 million worth and sitting at .02... 25 mill revs and 50 mill revenues 

Filings,bought some on this unusual high volume for a lotto

wow this stock has been the biggest pharma scam i maybe have ever seen! RS and now like 99% down in premarket to .013. what a joke this stock is. I bet they cant WAIT to add to the float and start selling again. yuk

CAPS one for 1,000 reverse split:

https://otce.finra.org/otce/dailyList?viewType=Symbol%2FName%20Changes

NITE with 1.5 mil bid up @ .014

WOW.Insider buy 50,000 @ 7.First in a while

HAPPY HOLIDAYS TO ALL

Nice :)

This could be big

Capstone Therapeutics Corp. (OTCQB:CAPS) ("the Company") and LipimetiX Development, Inc., the Company's drug development joint venture ("JV") announced today that the JV's lead commercial drug candidate, AEM-28-14, showed substantial and statistically-significant LDL cholesterol (LDLc) reductions in a hypercholesterolemic primate study at Wake Forest University. Following a single IV administration of escalating doses up to 5mg/kg, LDLc exhibited a mean reduction of 64% from baseline at 24 hours, 46% from baseline at 3 days and 16% from baseline at 7 days, despite the study animals remaining on a high fat/cholesterol diet through the full study.

A PDF accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/065505f4-bc99-4efc-b76d-b7d16c876ed3

Dennis I. Goldberg, PhD, President and CEO of LipimetiX Development, Inc. stated "AEM-28-14 has shown clinically-relevant levels of cholesterol reduction in multiple validated preclinical models and may be the most powerful lipid reduction agent yet discovered. Primate models are often predictive of a molecule's therapeutic performance in humans. Accordingly, we see the LDLc reduction in this primate model as consistent with the benefits that we hope to deliver to Homozygous Familial Hypercholesterolemia (HoFH) patients...powerful cholesterol lowering combined with duration of effect."

The JV's development goals are to conduct Phase 1a, 1b, and 2a human clinical trials with AEM-28-14 to show an acceptable safety profile and cholesterol reduction efficacy in HoFH, an orphan genetic disease characterized by extremely high LDLc due to inherited defects in the LDL receptor pathway from both parents. The hypercholesterolemia associated with HoFH is difficult to treat since it is refractory to drugs and biologics, such as statins and PCSK9 inhibitors, that increase the expression and functionality of the LDL receptor in normal patients.

Chimeric Apolipoprotein E Mimetic Peptides

Apolipoprotein E (Apo E) is in a class of protein that occurs throughout the body. Apo E is essential for the normal metabolism of cholesterol and triglycerides. After a meal, the postprandial (or post-meal) lipid load is packaged in lipoproteins and secreted into the blood stream. Apo E targets cholesterol and triglyceride-rich lipoproteins to specific receptors in the liver, decreasing these levels in the blood. Defective metabolism of cholesterol and triglyceride-rich lipoprotein remnants plays an important role in the development of diseases of the coronary, cerebral and peripheral arteries often leading to heart attack and stroke.

The University of Alabama at Birmingham ("UAB") scientists patented the first chimeric Apo E mimetic peptide in 1999, reducing the 299 amino acid native Apo E into a 28 amino acid, dual domain peptide that can be delivered therapeutically. One domain inserts into a lipoprotein surface and the second domain binds to the Apo E receptors in the liver. In 2010, our JV's founding scientist, Dr. Dennis Goldberg, obtained worldwide right to patents for Apo E mimetic peptides from the UAB Research Foundation ("UABRF"). The JV has an Exclusive License Agreement with the University of Alabama at Birmingham Research Foundation for AEM-28 and its analogs.

The JV has continued research in to a new generation of chimeric Apo E peptides and has discovered AEM-28-14, resulting in a USPTO and PCT patent filing in 2015 supporting claims for a broad domain of Apo E mimetic peptides. AEM-28-14 was found to be more potent (as tested in multiple

$0.02 per share cash. No current research underway. Will be at Rodman & Renshaw looking for investment to continue work.

This stock should imo be trading sub penny. Arent they going through their money like water for research that amounts to nothing?

$CAPS recent news/filings

bullish
charts that are focused on long term growth and are not affected by earnings reports

## source: finance.yahoo.com

Thu, 23 Jul 2015 12:03:11 GMT ~ CAPSTONE THERAPEUTICS CORP. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits


read full: http://biz.yahoo.com/e/150723/caps8-k.html
*********************************************************

Thu, 23 Jul 2015 12:00:00 GMT ~ Capstone Therapeutics Announces Patent Application for Novel, More Potent Chimeric Apo E Mimetic Peptides

[GlobeNewswire] - TEMPE, Ariz. -- Capstone Therapeutics Corp. (OTCQB:CAPS) ("the Company") and its joint venture affiliate, LipimetiX Development, Inc. ("JV"), announced today the conversion of a provisional ...

read full: http://finance.yahoo.com/news/capstone-therapeutics-announces-patent-application-120000212.html
*********************************************************

Mon, 22 Jun 2015 16:53:30 GMT ~ CAPSTONE THERAPEUTICS CORP. Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to a


read full: http://biz.yahoo.com/e/150622/caps8-k.html
*********************************************************

Fri, 19 Jun 2015 20:30:00 GMT ~ Capstone Therapeutics Corp. Q1 2015 Operating Update Call scheduled for 4:30 pm ET today


read full: http://biz.yahoo.com/cc/9/144899.html
*********************************************************

Tue, 02 Jun 2015 15:43:03 GMT ~ CAPSTONE THERAPEUTICS CORP. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits


read full: http://biz.yahoo.com/e/150602/caps8-k.html
*********************************************************

$CAPS charts

basic chart ## source: stockcharts.com



basic chart ## source: stockscores.com



big daily chart ## source: stockcharts.com



big weekly chart ## source: stockcharts.com



$CAPS company information

## source: otcmarkets.com

Link: http://www.otcmarkets.com/stock/CAPS/company-info
Ticker: $CAPS
OTC Market Place: OTCQB
CIK code: 0000887151
Company name: Capstone Therapeutics Corp
Company website: http://www.capstonethx.com
Incorporated In: DE, USA

Business Description: Capstone Therapeutics Corp. is a biotechnology company committed to developing a pipeline of novel therapeutic peptides aimed at helping patients with under-served medical conditions.

$CAPS share structure

## source: otcmarkets.com

Market Value: $8,585,936 a/o Jul 27, 2015
Shares Outstanding: 40,885,411 a/o Mar 13, 2015
Float: Not Available
Authorized Shares: 100,000,000 a/o Mar 13, 2015
Par Value: 0.0005

$CAPS extra dd links

Company name: Capstone Therapeutics Corp
Company website: http://www.capstonethx.com

## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/CAPS/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/CAPS/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=CAPS+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=CAPS+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=CAPS+Industry

## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/CAPS/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/CAPS/news - http://finance.yahoo.com/q/h?s=CAPS+Headlines

## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/CAPS/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/CAPS/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/CAPS/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/CAPS/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/CAPS/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/CAPS/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/CAPS/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/CAPS/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=CAPS+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/CAPS
DTCC (dtcc.com): http://search2.dtcc.com/?q=Capstone+Therapeutics+Corp&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Capstone+Therapeutics+Corp
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Capstone+Therapeutics+Corp&x=0&y=0
WHOIS (domaintools.com): http://whois.domaintools.com/http://www.capstonethx.com
Alexa (alexa.com): http://www.alexa.com/siteinfo/http://www.capstonethx.com#
Corporate website internet archive (archive.org): http://web.archive.org/web/*/http://www.capstonethx.com

## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/CAPS/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/CAPS
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/CAPS/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/CAPS/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/CAPS/sec-filings
Edgar filings (sec.gov): http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000887151&owner=exclude&count=40
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/CAPS/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/CAPS/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/CAPS/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/CAPS/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=CAPS&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=CAPS
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/CAPS/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=CAPS+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=CAPS+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=CAPS
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=CAPS
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=CAPS+Cash+Flow&annual

## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/CAPS/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=CAPS+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/CAPS.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=CAPS
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/CAPS/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/CAPS/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/CAPS/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/CAPS/insider-transactions

## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/CAPS
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/CAPS
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/CAPS:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=CAPS
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=CAPS



$CAPS DD Notes ~ http://www.ddnotesmaker.com/CAPS

No run! Nor will there ever be. These guys go through money like water

Big news out could see run watch for pre market buys

wow last post here was back in feb! Totally no demand here!

nope. ill look. I still don't like you. so quit messaging me. later.

Caps will be a dollar stock soon. Did yu see how many shares are being acquired ?

no, I don't care, actually. I did mid .20s a looong time ago.

oh i get it. you just said you WERE long. You must have sold WAY too early then. Sucks to be you.

you're an idiot. if you read all my posts here you see I was long. these posts were over a year ago.

And now the stock is in the .30s with BVF buying millions of shares over the last several months. go away idiot!

CAPS+48.00% Nice Rise Today~

.19x.20

.19c close.. On air. .. Probably air everyday

Not watching anything other than price. Don't care. Will sell and be gone for ever

Did yu look at today though? All these bullsht options awarded to these thieves?

im in on SBFM it looks better chart wise than CAPS

volumes picking up here

a run is brewing here

was going to make this my next sleeper but i changed my mind, have a better one than this next.

feels like it. i used to trade this back in the day. traded like a snail then too. may just bore everyone to death

nice, im thinking this wakes up soon.

goldon cross forming

another insider buy just posted 175K

volumes hitting here, this is a sleeper.

CAPS is a good example of what happens when you have NO SELLERS. The stock doesn't move! Sitting at .15x.18 and now .155x.20.. you think buyers are going to buy a 30% intra spread? Come on now. You have no sellers, bidders sitting there, stock is motionless - people think sellers are a bad thing - this is what creates a market, people. Think outside the box and ignore the general fallacies of typical ihub traders.

$CAPS was pretty much .152x.18 all day today

have it on close watch, may i will entry

Took some .165 $CAPS

whats up?!

Anyone here notice that yahoo CAPS message board is cancelled? Why so?

http://quotes.barrons.com/caps/ownership